- Home
- XFOR vs TWIN Comparison
XFOR vs TWIN Comparison
Compare XFOR & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | TWIN |
|---|---|---|
| Founded | 2014 | 1918 |
| Country | United States | United States |
| Employees | 143 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 269.7M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | XFOR | TWIN |
|---|---|---|
| Price | $3.69 | $17.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $28.50 | $12.00 |
| AVG Volume (30 Days) | ★ 543.5K | 55.0K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | N/A | ★ $340,738,000.00 |
| Revenue This Year | $1,263.94 | $10.79 |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $11.76 |
| Revenue Growth | N/A | ★ 15.45 |
| 52 Week Low | $0.17 | $6.16 |
| 52 Week High | $6.63 | $19.63 |
Technical Indicators
Market Signals| Indicator | XFOR | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 49.10 |
| Support Level | $3.52 | $14.80 |
| Resistance Level | $4.09 | $18.00 |
| Average True Range (ATR) | 0.23 | 0.89 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 83.50 | 40.64 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.